Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, September 20, 2014
Technology Networks
 
Register | Sign in
Home Page > Videos > sciFLEXARRAYER - ultra-low volume dispensing systems for R and D and manufacturing
  Videos

Return

sciFLEXARRAYER - ultra-low volume dispensing systems for R and D and manufacturing
Scienion AG

sciFLEXARRAYER drop-on-demand, inkjet-printing instruments are made for automated ultra-low-volume liquid-handling of biological samples such as DNA, proteins, antibodies and even whole cells. Organic solvents based samples, nano-particles and many other liquids can be handled too. Typical applications are the manufacturing of biosensors, loading of MALDI targets and printing of microarrays, e.g. directly at the bottom of microtiter-plate wells. These microarrays are made of e.g. DNA, proteins, antibodies and glycans, as well as from antigens of different sources for allergy-testing. In order to meet the brought variety of needs of our customers from early research to high-throughput manufacturing, Scienion offers tailor-made systems of different sizes and throughput, ranging from the basic S1 over S3, S5, S11 and SX to the ultimate tool for high-performance manufacturing, the S100.

Request more information
Company product page



For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here

Scientific News
Salmonella - Why Live Vaccines May Be Most Effective
University of Cambridge researchers investigated the effectiveness of vaccines against Salmonella.
Blood Cleanser for Sepsis
Dialysis-like ‘biospleen’ quickly filters bacteria, fungi and toxins.
Intestinal Bacteria Needed for Strong Flu Vaccine Responses in Mice
Study demonstrate a dependency on gut bacteria for strong immune responses to the seasonal flu and inactivated polio vaccines.
Blocking One Receptor on Cells Could Halt Rheumatoid Arthritis
Researchers uncovered multiple pathological processes driven by the activation of the receptor.
New Defence Mechanism Against Viruses Discovered
Mechanism may represent one of the oldest defence mechanisms against viruses in evolutionary history.
Novel Immunotherapy Breast Cancer Vaccine
Vaccine Decreases Recurrence in HER2 Positive Breast Cancer Patients.
Cell ‘Memory’ Could be Key to Strengthen Vaccine Efficacy
Virginia Tech Carilion Research Institute scientists uncover immune system secret.
Apitope Treatment Approach Published in Nature Communications
Scientists discover how to 'switch off' autoimmune diseases.
NIH-Led Scientists Discover HIV Antibody that Binds to Novel Target on Virus
The antibody, 35O22, prevents 62 percent of known HIV strains from infecting cells in the laboratory.
Breakthrough Melanoma Treatment, Keytruda, Developed
New immunotherapy launched in the US for treatment of adults with advanced melanoma, developed using antibody humanization expertise at UK’s MRC Technology.
Scroll Up
Scroll Down
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv